Upgrade to SI Premium - Free Trial

Ocular Therapeutix (OCUL) PT Lowered to $13 at Cowen

July 11, 2018 7:02 AM
Cowen lowered its price target on Ocular Therapeutix (NASDAQ: OCUL) to $13.00 (from $60.00) while maintaining a Outperform rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change